The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

References 16

1. 1.

   Antman K., Gale R. P. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Ann Intern Med. 1988;108(4):570-574.

   Not in our library10.7326/0003-4819-108-4-570

2. 2.

   Brinkley D. Quality of life in cancer trials. Br Med J (Clin Res Ed). 1985;291(6497):685-686.

   Not in our library10.1136/bmj.291.6497.685

3. 3.
   Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer · 1987

   No notice
4. 4.

   Carmo-Pereira J., Costa F. O., Henriques E., Godinho F., Cantinho-Lopes M. G., Sales-Luis A., Rubens R. D. A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer. 1987;56(4):471-473.

   Not in our library10.1038/bjc.1987.226

5. 5.

   Cortes E. P., Holland J. F., Glidewell O. Amputation and adriamycin in primary osteosarcoma: a 5-year report. Cancer Treat Rep. 1978;62(2):271-277.

   Not in our library

6. 6.

   De Vita V. T., Hubbard S. M., Longo D. L. The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1987;47(22):5810-5824.

   Not in our library

7. 7.

   DeVita V. T. Dose-response is alive and well. J Clin Oncol. 1986;4(8):1157-1159.

   Not in our library10.1200/jco.1986.4.8.1157

8. 8.

   Frei E., Canellos G. P. Dose: a critical factor in cancer chemotherapy. Am J Med. 1980;69(4):585-594.

   Not in our library10.1016/0002-9343(80)90472-6

9. 9.
   Assessment of response to therapy in advanced breast cancer · 1977

   No notice
10. 10.

    Henderson I. C., Hayes D. F., Gelman R. Dose-response in the treatment of breast cancer: a critical review. J Clin Oncol. 1988;6(9):1501-1515.

    Not in our library10.1200/jco.1988.6.9.1501

11. 11.

    Hortobagyi G. N. The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer. Bone Marrow Transplant. 1988;3(6):525-530.

    Not in our library

12. 12.

    Hubbard S. M., Barkes P., Young R. C. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy. Cancer Treat Rep. 1978;62(9):1375-1377.

    Not in our library

13. 13.

    Jones R. B., Holland J. F., Bhardwaj S., Norton L., Wilfinger C., Strashun A. A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol. 1987;5(2):172-177.

    Not in our library10.1200/jco.1987.5.2.172

14. 14.

    Skipper H. E. Criteria associated with destruction of leukemia and solid tumor cells in animals. Cancer Res. 1967;27(12):2636-2645.

    Not in our library

15. 15.

    Steiner R., Stewart J. F., Cantwell B. M., Minton M. J., Knight R. K., Rubens R. D. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol. 1983;19(11):1553-1557.

    Not in our library10.1016/0277-5379(83)90085-8

16. 16.

    Wheeler R. H., Ensminger W. D., Thrall J. H., Anderson J. L. High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia. Cancer Treat Rep. 1982;66(3):493-498.

    Not in our library

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.